Almenoff June Sherie

Tenax Therapeutics, Inc. · Director

Almenoff June Sherie is listed in filings as Director at Tenax Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 13, 2026, including purchase activity. Recent filings connect the profile to Tenax Therapeutics, Inc. (TENX). The current snapshot covers public activity from Nov 19, 2025 to Jan 13, 2026. Reported amounts are shown as $665 to $399.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Tenax Therapeutics, Inc.TENX$14k1.9k sharesBuyNov 18, 2025$7.52$15.83